Responding to People in Danger: Development and Feasibility study
Research type
Research Study
Full title
Responding to people in danger. A development and feasibility study to co-develop a community pharmacy response service for domestic abuse and suicidal ideation.
IRAS ID
309018
Contact name
Josie Solomon
Contact email
Sponsor organisation
University of Lincoln
Duration of Study in the UK
1 years, 8 months, 26 days
Research summary
The COVID-19 pandemic has increased the number of people feeling suicidal, and has increased domestic abuse. Both situations are distressing and can be fatal. However, these deaths are preventable, and harm can be minimised, if people are able to access timely and appropriate help. Community pharmacies may be suitable places to access this help as they are highly accessible with long opening hours and no requirements for appointments.
This project aims to co-develop and then test the feasibility of a community pharmacy response service for people in danger from either suicide or domestic abuse.
There are two stages to this project.
Stage 1 (service co-development): This will be achieved by one-to-one interviews with experts, lay focus groups and co-development workshops (with members of the public and pharmacy staff). We will co-develop and refine the name, concept, design and resources for the new service. Resources will include developing a pharmacist clinical assessment and referral tool, and a training package for the pharmacy staff.Stage 2 (feasibility in pharmacies): The service will be tested for feasibility in 12 pharmacies. Eight will deliver the service and 4 will not (they will act as controls). We will collect data from each pharmacy to explore how many people
access the service and the numbers of people referred. Focus groups will be held to understand how pharmacy staff felt about offering the service to assess acceptability of delivering the service. To understand public acceptability, we will interview pharmacy customers and do a public survey. A final workshop will be arranged with all pharmacy staff, research team and advisory groups.An advisory panel of members of the public has been set up to work with the researchers throughout the project. A PPIE representative is also part of the formal research team to ensure lay views are further represented.
REC name
North West - Preston Research Ethics Committee
REC reference
22/NW/0016
Date of REC Opinion
31 May 2022
REC opinion
Further Information Favourable Opinion